Literature DB >> 21168906

Hodgkin lymphoma in 2 children with chronic granulomatous disease.

Saul Oswaldo Lugo Reyes, Felipe Suarez, Rose-Marie Herbigneaux, Hélène Pacquement, Yves Réguerre, Jean-Pierre Rivière, Maylis de Suremain, Yoann Rose, Jacqueline Feinberg, Nizar Malahoui, Alain Fischer, Stéphane Blanche, Jean-Laurent Casanova, Capucine Picard, Jacinta Bustamante.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21168906      PMCID： PMC3038468          DOI： 10.1016/j.jaci.2010.10.049

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

1.  Increased risk of malignancy for patients with chronic granulomatous disease and its possible link to the pathogenesis of cancer.

Authors:  E A Weel; W K Redekop; R S Weening
Journal:  Eur J Cancer       Date:  1996-04       Impact factor: 9.162

2.  Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.

Authors:  Tomonori Nakazato; Keisuke Ito; Yasuo Ikeda; Masahiro Kizaki
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

3.  Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma.

Authors:  Qing Lan; Tongzhang Zheng; Min Shen; Yawei Zhang; Sophia S Wang; Shelia H Zahm; Theodore R Holford; Brian Leaderer; Peter Boyle; Stephen Chanock
Journal:  Hum Genet       Date:  2006-12-06       Impact factor: 4.132

4.  Acute lymphoblastic leukemia in a patient with chronic granulomatous disease and a novel mutation in CYBB: first report.

Authors:  Baruch Wolach; Shifra Ash; Ronit Gavrieli; Batia Stark; Isaac Yaniv; Dirk Roos
Journal:  Am J Hematol       Date:  2005-09       Impact factor: 10.047

5.  Chronic granulomatous disease. Report on a national registry of 368 patients.

Authors:  J A Winkelstein; M C Marino; R B Johnston; J Boyle; J Curnutte; J I Gallin; H L Malech; S M Holland; H Ochs; P Quie; R H Buckley; C B Foster; S J Chanock; H Dickler
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

Review 6.  Immunodeficiency-associated lymphomas.

Authors:  Huy Tran; Jamie Nourse; Sara Hall; Michael Green; Lyn Griffiths; Maher K Gandhi
Journal:  Blood Rev       Date:  2008-05-05       Impact factor: 8.250

7.  Glioblastoma multiforme in a patient with chronic granulomatous disease treated with subtotal resection, radiation, and thalidomide: case report of a long-term survivor.

Authors:  Dolly G Aguilera; Tadanori Tomita; Veena Rajaram; Jason Fangusaro; Ben Z Katz; Stanford Shulman; Stewart Goldman
Journal:  J Pediatr Hematol Oncol       Date:  2009-12       Impact factor: 1.289

Review 8.  Development of cancer in patients with primary immunodeficiencies.

Authors:  Katerina Salavoura; Aggeliki Kolialexi; George Tsangaris; Ariadni Mavrou
Journal:  Anticancer Res       Date:  2008 Mar-Apr       Impact factor: 2.480
  8 in total
  5 in total

1.  B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency.

Authors:  Hannelore I Bax; Alexandra F Freeman; Victoria L Anderson; Per Vesterhus; Dan Laerum; Stefania Pittaluga; Wyndham H Wilson; Steven M Holland
Journal:  J Clin Immunol       Date:  2013-06-26       Impact factor: 8.317

Review 2.  Advances in basic and clinical immunology in 2011.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

Review 3.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

4.  Clinical Features, Non-Infectious Manifestations and Survival Analysis of 161 Children with Primary Immunodeficiency in Mexico: A Single Center Experience Over two Decades.

Authors:  Saul Oswaldo Lugo Reyes; Guadalupe Ramirez-Vazquez; Alonso Cruz Hernández; Edgar A Medina-Torres; Ana Belen Ramirez-Lopez; Corín España-Cabrera; Citlali A Hernandez-Lopez; Marco A Yamazaki-Nakashimada; Francisco J Espinosa-Rosales; Sara E Espinosa-Padilla; Chiharu Murata
Journal:  J Clin Immunol       Date:  2015-12-28       Impact factor: 8.317

5.  A novel mutation in NCF2 resulting in very-early-onset colitis and juvenile idiopathic arthritis in a patient with chronic granulomatous disease.

Authors:  Suzan AlKhater
Journal:  Allergy Asthma Clin Immunol       Date:  2019-11-21       Impact factor: 3.406
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.